Grimes & Company, Inc. Abbott Laboratories Transaction History

Grimes & Company, Inc.

$3.58 Billion
Q2 2025

A detailed history of Grimes & Company, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Grimes & Company, Inc. holds 59,789 shares of ABT stock, worth $7.57 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

59,789

Previous 58,975 1.38%

Holding current value

$7.57 Million

Previous $7.82 Million 3.94%

% of portfolio

0.23%

Previous 0.25%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 22, 2025	BUY	$123.95 - $138.08 $100,895 - $112,397	814 Added 1.38%	59,789 $8.13 Million
Q1 2025 Apr 17, 2025	BUY	$111.1 - $140.22 $94,546 - $119,327	851 Added 1.46%	58,975 $7.82 Million
Q4 2024 Jan 21, 2025	BUY	$111.93 - $119.39 $20,035 - $21,370	179 Added 0.31%	58,124 $6.57 Million
Q3 2024 Oct 22, 2024	BUY	$100.07 - $118.13 $118,883 - $140,338	1,188 Added 2.09%	57,945 $6.61 Million
Q2 2024 Jul 22, 2024	SELL	$100.73 - $112.44 $22,059 - $24,624	-219 Reduced 0.38%	56,757 $5.9 Million
Q1 2024 Apr 17, 2024	SELL	$109.52 - $120.96 $6,352 - $7,015	-58 Reduced 0.1%	56,976 $6.48 Million
Q4 2023 Jan 24, 2024	BUY	$90.19 - $110.4 $223,761 - $273,902	2,481 Added 4.55%	57,034 $6.28 Million
Q3 2023 Oct 19, 2023	BUY	$95.53 - $114.62 $21,780 - $26,133	228 Added 0.42%	54,553 $5.28 Million
Q2 2023 Jul 19, 2023	SELL	$100.78 - $112.29 $13,605 - $15,159	-135 Reduced 0.25%	54,325 $5.92 Million
Q1 2023 Apr 20, 2023	BUY	$96.86 - $114.01 $1,937 - $2,280	20 Added 0.04%	54,460 $5.51 Million
Q4 2022 Jan 25, 2023	BUY	$95.06 - $111.52 $1,045 - $1,226	11 Added 0.02%	54,440 $0
Q3 2022 Oct 28, 2022	SELL	$96.76 - $112.03 $15,675 - $18,148	-162 Reduced 0.3%	54,429 $5.27 Million
Q2 2022 Jul 22, 2022	BUY	$102.07 - $123.37 $11,533 - $13,940	113 Added 0.21%	54,591 $5.93 Million
Q1 2022 May 06, 2022	BUY	$114.02 - $139.04 $1,596 - $1,946	14 Added 0.03%	54,478 $6.45 Million
Q4 2021 Feb 01, 2022	SELL	$115.53 - $141.46 $135,632 - $166,074	-1,174 Reduced 2.11%	54,464 $7.67 Million
Q3 2021 Nov 08, 2021	BUY	$116.66 - $129.06 $14,232 - $15,745	122 Added 0.22%	55,638 $6.57 Million
Q2 2021 Aug 04, 2021	SELL	$105.79 - $124.53 $10,367 - $12,203	-98 Reduced 0.18%	55,516 $6.44 Million
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $867,999 - $1.02 Million	7,975 Added 16.74%	55,614 $6.67 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $1,008 - $1,224	-11 Reduced 0.02%	47,639 $5.19 Million
Q2 2020 Jul 31, 2020	BUY	$76.57 - $98.0 $4,517 - $5,782	59 Added 0.12%	47,650 $4.36 Million
Q1 2020 May 05, 2020	BUY	$62.82 - $91.86 $125,828 - $183,995	2,003 Added 4.39%	47,591 $3.76 Million
Q4 2019 Feb 05, 2020	BUY	$78.51 - $87.4 $12,404 - $13,809	158 Added 0.35%	45,588 $3.96 Million
Q3 2019 Nov 05, 2019	SELL	$81.84 - $88.74 $45,012 - $48,807	-550 Reduced 1.2%	45,430 $3.8 Million
Q2 2019 Jul 30, 2019	BUY	$72.88 - $85.0 $11,733 - $13,685	161 Added 0.35%	45,980 $3.87 Million
Q1 2019 May 02, 2019	SELL	$66.22 - $80.06 $2,582 - $3,122	-39 Reduced 0.09%	45,819 $3.66 Million
Q4 2018 Feb 01, 2019	SELL	$65.56 - $74.27 $6,228 - $7,055	-95 Reduced 0.21%	45,858 $3.32 Million
Q3 2018 Nov 09, 2018	SELL	$60.81 - $73.36 $8,087 - $9,756	-133 Reduced 0.29%	45,953 $3.37 Million
Q2 2018 Aug 10, 2018	BUY	$57.57 - $63.54 $43,177 - $47,655	750 Added 1.65%	46,086 $2.81 Million
Q1 2018 May 07, 2018	BUY	$56.27 - $63.62 $626,735 - $708,599	11,138 Added 32.57%	45,336 $2.72 Million
Q4 2017 Feb 05, 2018	BUY	$53.68 - $57.47 $1.62 Million - $1.73 Million	30,186 Added 752.39%	34,198 $1.95 Million
Q3 2017 Nov 03, 2017	BUY	$48.06 - $53.64 $192,816 - $215,203	4,012	4,012 $214,000

Others Institutions Holding ABT

# of Institutions

3,572

Shares Held

1.37B

Call Options Held

9.75M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $222B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grimes & Company, Inc. with notifications on news.

Account

Grimes & Company, Inc. Abbott Laboratories Transaction History